•  
logo
  • Home
  • Pharmaceutical R&D Services
    • Customized Stroke Models
      • Animal Modeling of Stroke
      • In Vitro Modeling of Stroke
    • Pathogenic Mechanism Analysis
      • Analysis of Ischemia-Triggered Glutamate Excitotoxicity
      • Molecular Mechanism Analysis of Oxidative Stress in Stroke
      • Analysis of Neuroinflammatory Mechanisms in Stroke
      • Molecular Mechanism Analysis of Ischemia-Reperfusion Injury
      • Cell Death Mechanism Analysis in Stroke
      • Epigenetic Mechanism Analysis in Stroke
      • Analysis of Gut Microbiota in Stroke
    • Stroke Drug Development Services
      • By Drug Modality
        • Small Molecule Drugs for Stroke
        • Neuropeptides
        • Monoclonal Antibodies for Stroke
        • Stem Cell-Based Therapies for Stroke
      • By Drug Action
        • Neuroprotective Agents Against Stroke
        • Thrombolytics for Stroke
        • Anticoagulant Drugs
        • Antiplatelet Drugs for Stroke
      • Customized Biospecimen Collection and Analysis Services
    • Drug Delivery System Development for Stroke
      • Nanoparticle-Based Drug Delivery Systems
      • Liposome-Based Drug Delivery Systems
      • Exosome-Based Drug Delivery Systems
      • Nasal Drug Delivery Systems
      • Virus-Based Gene Delivery Systems
    • Preclinical Evaluation Services
      • ADME/DMPK for Stroke Drugs
      • Drug Efficacy Testing for Stroke
      • Safety Assessment for Stroke Drugs
      • In Vitro Pharmacology for Stroke Drugs
    • Stroke Biomarker Development Services
      • Stroke-Related Protein Biomarkers
      • Stroke-Related RNA Biomarkers
      • Stroke-Related Metabolite Biomarkers
      • Stroke-Related Lipid Biomarkers
      • Stroke Biomarker Panels
  • Therapeutic Areas
    • Preclinical Ischemic Stroke Research Services
      • Thrombotic Stroke
      • Embolic Stroke
      • Cardioembolic Stroke
      • Cryptogenic Stroke
    • Preclinical Hemorrhagic Stroke Research Services
      • Intracerebral Hemorrhage
      • Subarachnoid Hemorrhage
    • Preclinical Transient Ischemic Attack Research Services
  • Virtual Booth
    • Brochures
    • Stroke Models
    • Case Studies
    • Protocols
  • Resources
    • Research Resources
    • Technical Notes
  • Company
    • Contact Us
    • About Us
    • Careers
Search

 

We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy

Stroke Models

  1. Home
  2. Virtual Booth
  3. Stroke Models

Fill In This Form to Get Our Virtual Booth.

A Comprehensive Overview of Each Experimental Stroke Model

Insights on increasing the translational value of clients' preclinical stroke research.

Overview of Intraluminal Filament tMCAO Model

Overview of Photochemically-Induced Stroke Rodent Models

Overview of Intraluminal Filament pMCAO Model

Overview of ET-1-Induced MCAO Model

Overview of Global Cerebral Ischemia Models

Overview of In Vitro BBB Models

Overview of In Vitro Oxygen Glucose Deprivation (OGD) Models

 Ace Therapeutics Preclinical CRO for Stroke

Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.

Quick Links
Home Pharmaceutical R&D Services Therapeutic Areas Resources
About us Contact us Careers
Contact Us

Copyright © 2025 Ace Therapeutics. All rights reserved.